OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ...
In an increasingly xenophobic country, Salt Lake City’s benevolent attitude toward immigrants is a strange anomaly. Can its ...
The government’s flagship development program, the ARREST Agenda for Inclusive Development, is facing intense scrutiny ...
The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation ...
Affinity Bancshares, Inc. Adopts Stock Repurchase ProgramThe Associated PressCOVINGTON, Ga. COVINGTON, Ga.–(BUSINESS WIRE)–Jan 7, 2026– Affinity Bancshares, Inc. (the “Company”) (Nasdaq: AFBI), the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results